These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35175647)

  • 1. Antibody titers after SARS-CoV-2 mRNA vaccination in patients with aplastic anemia-A single-center study.
    Walter J; Kricheldorf K; Isfort S; Brümmendorf TH; Panse J; Beier F
    Eur J Haematol; 2022 Jun; 108(6):528-531. PubMed ID: 35175647
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 mRNA vaccination of aplastic anemia patients is safe and effective.
    Pothast CR; van Dijk K; Pool ES; Halkes CJM; Heemskerk MHM; Tjon JM
    Am J Hematol; 2023 Feb; 98(2):E20-E23. PubMed ID: 36371670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
    Hagihara M; Sugi T; Hayashi H; Nakashima S; Ohara S; Imai Y; Nakano H; Uchida T; Inoue M; Mitamura K
    Rinsho Ketsueki; 2023; 64(2):133-136. PubMed ID: 36990734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Hepatitis-associated Aplastic Anemia Following COVID-19 mRNA Vaccination.
    Yamamoto M; Keino D; Sumii S; Yokosuka T; Goto H; Inui A; Sogo T; Kawakami M; Tanaka M; Yanagimachi M
    Intern Med; 2023 Jun; 62(12):1813-1816. PubMed ID: 36948624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
    Valanparambil RM; Carlisle J; Linderman SL; Akthar A; Millett RL; Lai L; Chang A; McCook-Veal AA; Switchenko J; Nasti TH; Saini M; Wieland A; Manning KE; Ellis M; Moore KM; Foster SL; Floyd K; Davis-Gardner ME; Edara VV; Patel M; Steur C; Nooka AK; Green F; Johns MA; O'Brein F; Shanmugasundaram U; Zarnitsyna VI; Ahmed H; Nyhoff LE; Mantus G; Garett M; Edupuganti S; Behra M; Antia R; Wrammert J; Suthar MS; Dhodapkar MV; Ramalingam S; Ahmed R
    J Clin Oncol; 2022 Nov; 40(33):3808-3816. PubMed ID: 35759727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Cecchi N; Giannotta JA; Barcellini W; Fattizzo B
    Br J Haematol; 2022 Mar; 196(6):1334-1336. PubMed ID: 34783367
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired aplastic anemia following SARS-CoV-2 vaccination.
    Röth A; Bertram S; Schroeder T; Haverkamp T; Voigt S; Holtkamp C; Klump H; Wörmann B; Reinhardt HC; Alashkar F
    Eur J Haematol; 2022 Aug; 109(2):186-194. PubMed ID: 35592930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
    Kanai D; Wakui H; Haze T; Azushima K; Kinguchi S; Tsukamoto S; Kanaoka T; Urate S; Toya Y; Hirawa N; Kato H; Watanabe F; Hanaoka K; Hanaoka M; Mitsuhashi H; Yamaguchi S; Ohnishi T; Tamura K
    Clin Exp Nephrol; 2022 Oct; 26(10):988-996. PubMed ID: 35751753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?
    Tabata S; Hosoi H; Murata S; Takeda S; Mushino T; Sonoki T
    J Autoimmun; 2022 Jan; 126():102782. PubMed ID: 34920343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Lahav Sher M; Barsha H; Shalabna E; Zolotarevsky A; Lavie O; Kedar R; Riskin-Mashiah S
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():148-154. PubMed ID: 35653903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
    Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
    Front Immunol; 2021; 12():780594. PubMed ID: 34925359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review.
    Guerra ENS; de Castro VT; Amorim Dos Santos J; Acevedo AC; Chardin H
    Front Immunol; 2022; 13():1006040. PubMed ID: 36203571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic Status According Severe Acute Respiratory Syndrome Coronavirus 2 in Patients After Orthotopic Heart Transplantation.
    Kuczaj A; Przybyłowski P
    Transplant Proc; 2022 May; 54(4):901-904. PubMed ID: 35414422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination.
    Kurahashi Y; Furukawa K; Sutandhio S; Tjan LH; Iwata S; Sano S; Tohma Y; Ohkita H; Nakamura S; Nishimura M; Arii J; Kiriu T; Yamamoto M; Nagano T; Nishimura Y; Mori Y
    J Infect Dis; 2022 Oct; 226(8):1391-1395. PubMed ID: 35512332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection.
    Evans JP; Zeng C; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL
    Sci Transl Med; 2022 Mar; 14(637):eabn8057. PubMed ID: 35166573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
    van Gils MJ; van Willigen HDG; Wynberg E; Han AX; van der Straten K; Burger JA; Poniman M; Oomen M; Tejjani K; Bouhuijs JH; Verveen A; Lebbink R; Dijkstra M; Appelman B; Lavell AHA; Caniels TG; Bontjer I; van Vught LA; Vlaar APJ; Sikkens JJ; Bomers MK; Russell CA; Kootstra NA; Sanders RW; Prins M; de Bree GJ; de Jong MD;
    Cell Rep Med; 2022 Jan; 3(1):100486. PubMed ID: 35103254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition of Antibody Titers after SARS-CoV-2 mRNA Vaccination in Japanese Healthcare Workers.
    Kitabatake M; Ouji-Sageshima N; Sonobe S; Furukawa R; Konda M; Hara A; Aoki H; Suzuki Y; Imakita N; Nakano A; Fujita Y; Shichino S; Nakano R; Ueha S; Kasahara K; Muro S; Yano H; Matsushima K; Ito T
    Jpn J Infect Dis; 2023 Jan; 76(1):72-76. PubMed ID: 36047181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
    Ogura W; Ohtsuka K; Matsuura S; Okuyama T; Matsushima S; Yamasaki S; Miyagi H; Sekiguchi K; Ohnishi H; Watanabe T
    Viruses; 2022 May; 14(5):. PubMed ID: 35632698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
    Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.